Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Most Shorted Stocks
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Most Shorted Stocks
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
PCCLICK
Stock Latest News
Private Companies
Phase 3 Schizophrenia Trial Results Highlight Potential of Click Therapeutics’ CT-155
2m ago
CLICK
Premium
Private Companies
Click Therapeutics Adds Former Novo Nordisk Executive to Board
2M ago
CLICK
Premium
Private Companies
Click Therapeutics Sharpens Migraine Focus and Femtech Strategy in Data-Driven Growth Push
3M ago
CLICK
Premium
Private Companies
Click Therapeutics Highlights Femtech Opportunity in Menstrual Migraine and Data Integration
3M ago
CLICK
Premium
Private Companies
Click Therapeutics Expands Migraine Digital Therapeutics Strategy and Showcases Growth Agenda
3M ago
CLICK
Premium
Private Companies
Click Therapeutics Highlights Expansion Into OTC Digital Migraine Therapeutics
3M ago
CLICK
Premium
Private Companies
Click Therapeutics CEO Highlights Talent Strategy at HLTH Europe
3M ago
CLICK
Premium
Private Companies
Click Therapeutics Advances Migraine Digital Therapeutic Strategy and Highlights Growth Agenda
4M ago
CLICK
Premium
Private Companies
Click Therapeutics Highlights Digital Migraine Therapeutic and Decentralized Trial Approach
4M ago
CLICK
Premium
Private Companies
Click Therapeutics Emphasizes Growth Strategy and Migraine-Focused Digital Therapeutics in Weekly Updates
4M ago
CLICK
Premium
Private Companies
Click Therapeutics Strategy Chief to Discuss Digital Health M&A and Growth at Industry Summit
4M ago
CLICK
Premium
Private Companies
Click Therapeutics Strategy Chief to Discuss M&A and Growth at HealthTech Summit
4M ago
CLICK
Premium
Private Companies
Click Therapeutics Highlights Digital Therapeutic Focus on Migraine Burden
4M ago
CLICK
Premium
Private Companies
Click Therapeutics Highlights Digital Therapeutics Focus on Migraine Burden
4M ago
CLICK
Premium
Private Companies
Click Therapeutics Inc – Weekly Recap
4M ago
CLICK
Premium
Private Companies
Click Therapeutics Highlights Strategic Focus on Over-the-Counter Digital Therapeutics
4M ago
CLICK
Premium
Private Companies
Click Therapeutics Highlights Strategic Focus on Over-the-Counter Digital Therapeutics
4M ago
CLICK
Premium
Private Companies
Click Therapeutics Showcases Phase III Migraine Results and Expands Digital Health Strategy
5M ago
CLICK
Premium
Private Companies
Click Therapeutics Highlights Phase III Data and Publication for CT-132 Migraine Therapeutic
5M ago
CLICK
Premium
Private Companies
Click Therapeutics Highlights Positive Phase III Data for CT-132 Migraine Therapeutic
5M ago
CLICK
Premium
Private Companies
Click Therapeutics Positions Over-the-Counter Digital Therapeutics as New Growth Avenue
5M ago
CLICK
Premium
Private Companies
Click Therapeutics Highlights Over-the-Counter Digital Therapeutics Strategy at FT Summit
5M ago
CLICK
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
